News
MAQUET Medical Systems AG, registered office: Rastatt, Kehler Straße 31, 76437 Rastatt (AG Mannheim HRB 719044), an indirect subsidiary of Getinge AB, Sweden, submitted a request on 15 May 2025 to ...
AVON, Mass., May 13, 2025 /PRNewswire/ -- Cervos Medical, a wholly owned subsidiary of Ranfac Corp, is proud to announce the CERVOS® KeyPRP System has received official certification under the ...
Medline has signed a new distribution agreement with The Ohio State University Wexner Medical Center to become the health system’s prime vendor for medical-surgical supplies. Under the agreement, ...
The introduction of the enhanced STREAMLINE® Surgical System in conjunction with the recent launch of New World Medical's VIA360™ Surgical System underscores the company's ongoing commitment to ...
APYX), a developer of medical devices with a market capitalization of $41.76 million, has announced the U.S. Food and Drug Administration (FDA) clearance for its AYON Body Contouring System.
Bayhealth Medical Center faces a ... The lawsuit, filed last year, seeks class-action status to represent a host of Bayhealth patients who used the system’s website. Additionally, the hospital ...
Bihar is also looking to implement blockchain-based applications and solutions across other sectors including agriculture, land records, public distribution system, benefits tracking and ...
Bioactive components in traditional Chinese medicinal fungi, such as polysaccharides and terpenoids, exhibit neuroprotective, antioxidant, and anti-inflammatory effects relevant to central nervous ...
4d
GlobalData on MSNMedline signs agreement with Ohio State University to supply medical productsThe distribution of products and services will be facilitated by Medline's centre located in West Jefferson, Ohio, US.
We're honoring the Class of 2025 by spotlighting some of the best and brightest graduates from the Department of Medical and Molecular Sciences ... "I was always interested in the immune and ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results